Page last updated: 2024-12-06

n,n-carbonyldiimidazole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

N,N'-Carbonyldiimidazole (CDI) is a versatile reagent used in organic synthesis for the formation of amides, esters, and carbamates. It is a white, crystalline solid that is soluble in organic solvents such as tetrahydrofuran (THF), dichloromethane, and diethyl ether. CDI is synthesized by the reaction of imidazole with phosgene. It is a highly reactive compound that readily reacts with nucleophiles, making it a useful reagent for a variety of organic transformations. One of the most common applications of CDI is in the formation of amides. CDI reacts with carboxylic acids to form a mixed anhydride, which then reacts with an amine to form an amide. The reaction is typically carried out in a polar aprotic solvent such as THF or dichloromethane. CDI is also used to form esters and carbamates. The reaction of CDI with alcohols or amines, respectively, leads to the formation of esters or carbamates. CDI is a powerful reagent for organic synthesis, and its reactivity has been extensively studied by scientists. The ability of CDI to react with a variety of functional groups makes it a valuable tool for the development of new synthetic methods and the preparation of complex molecules. CDI is also studied for its potential applications in other areas, such as polymer chemistry and materials science.'

Cross-References

ID SourceID
PubMed CID68263
CHEMBL ID3903881
SCHEMBL ID1325
MeSH IDM0049735

Synonyms (141)

Synonym
NCIOPEN2_000076
n,n'-carbonyldiimidazole
carbonyl diimidazole
nsc67203
530-62-1
1-oxomethylenebis(n-imidazole)
nsc-67203
n,n-carbonyldiimidazole
1h-imidazole,1'-carbonylbis-
1,1'-carbonyldiimidazole
diimidazol-1-yl ketone
n,n'-carbonylbis(imidazole)
imidazole,1'-carbonyldi-
CDI ,
CDL ,
inchi=1/c7h6n4o/c12-7(10-3-1-8-5-10)11-4-2-9-6-11/h1-6
1,1'-carbonylbis(1h-imidazole)
1h-imidazole, 1-(1h-imidazol-1-ylcarbonyl)-
cdi, reagent grade
1h-imidazole, 1,1'-carbonylbis-
ccris 2606
ai3-60328
1,1'-carbonylbis-1h-imidazole
nsc 67203
imidazole, 1,1'-carbonyldi-
einecs 208-488-9
cdi, >=97.0% (t)
AC-10610
1,1-carbonyldiimidazole ,
carbodiimidazole
di(imidazol-1-yl)methanone
FT-0664272
AKOS000120676
di(1h-imidazol-1-yl)methanone
A7728
di-imidazol-1-yl-methanone
carbonyldiimidazol
1-[(1h-imidazol-1-yl)carbonyl]-1h-imidazole
1,1'-carbonyldiimidazol
ec 208-488-9
methanone, di-1h-imidazol-1-yl-
unii-63a10x1fsp
63a10x1fsp ,
1,1'-carbonyl diimidazole
n,n'-carbonyldiimidazole (cdi)
di-1h-imidazol-1-ylmethanone
STK917779
FT-0687282
BP-12399
FT-0606075
AM20100298
1,1'-carbonyldiimidazole-13c
1,1 '-carbonyldiimidazole
SCHEMBL1325
bis(imidazol-1-yl) ketone
n,n'-carbonyldiimidazole [mi]
bis(1h-imidazol-1-yl)methanone
1-(1h-imidazol-1-ylcarbonyl)-1h-imidazole
1-(1h-imidazol-1-ylcarbonyl)-1h-imidazole #
1,1'-carbonylbisimidazole
carbonyl-1,1'-dimidazole
1.1'-carbonyldiimidazole
1,1'-carbonyl-diimidazol
1,1'-carbonyl-bis[1h-imidazole]
1[(1h-imidazol-1-yl)carbonyl]-1h-imidazole
1,1'-carbonyl-bis-[1h-imidazole]
1,1'-carbonyldiimdazole
n,n-carbonyldimidazole
1,1-di-imidazol-1-yl-methanone
carbonyidimidazole
1,1'-carbonyidimidazole
carbonyl-1,1'-diimidazole
carbonyldimidazole
1,1'-carbonyl bis-1h-imidazole
1,1'-carbonyldi-imidazole
n,n''-carbonyldiimidazole
1,1'-carbonyl dimidazole
1,1'carbonyldiimidazol
diimidazol-1-yl-methanone
carbonyldiirnidazole
1,1'-carbonyldiimmidazol
1,1'carbonyldiimidazole
1,1'-carbonyl-diimidazole
1,1'- carbonyldiimidazole
cabonyldiimidazole
1,1'-cabonyldiimidazole
1.1'-carbonyl-diimidazole
1,1'carbonyldimidazole
n,n-carbonyidiimidazole
1,1'-carbonyl di-imidazole
di-(1h-imidazol-1-yl)methanone
di-1h-imidazolylmethanone
1,1'carbonyl-diimidazole
1,1' carbonyl-diimidazole
1-(1h-imidazol-1-yl-carbonyl)-1h-imidazole
1,1'-carbonylbis-1h -imidazole
1,1'-carbonyldi-1h-imidazole
1,1'-carbonylbis -1h-imidazole
1,1'carbonyl diimidazole
di-(imidazol-1-yl)methanone
1.1'carbonyldiimidazole
1,1'-carbonylbis-1 h-imidazole
1,1-'carbonyldiimidazole
carbonyidiimidazole
1-(1h-imidazol-1yl-carbonyl)-1h-imidazole
1.1' carbonyldiimidazole
1,1'-carbonyl-bis(1h-imidazole)
diimidazol-1-ylmethanone
1,1'-carbonyidiimidazole
1,1'-carbonyldimidazole
1,1'-(oxomethanediyl)bis-1h-imidazole
1,1' carbonyl diimidazole
di-1h-imidazol-1-yl-methanone
1,1'-carbonyldi imidazole
1,1' -carbonyldiimidazole
1,1 '-carbonyl-diimidazole
1,1'carbonylbis[1h-imidazole]
di(1h-imidazol-1-yl) methanone
1,1'-carbonylbis[1h-imidazole]
1,1' carbonyldiimidazole
W-200555
n,n'-carbonyl diimidazole(cdi)
mfcd00005286
DTXSID9038761
us9144538, 1'-1- carbonylimidazole
bdbm181135
us9138393, 1?-1- carbonylimidazole
F0001-1366
1-(1h-imidazole-1-carbonyl)-1h-imidazole
CS-W008844
cdi, purum, >=95.0% (t)
P17515
cdi, vetec(tm) reagent grade, 97%
CHEMBL3903881
Q418617
BCP01361
EN300-21023
cdi, 1,1'-carbonyldiimidazole
cdi crosslinker
1,1'-carbonyldiimidazole, >90%
PB47918
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (103)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (11.65)18.7374
1990's22 (21.36)18.2507
2000's25 (24.27)29.6817
2010's40 (38.83)24.3611
2020's4 (3.88)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.57

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.57 (24.57)
Research Supply Index4.67 (2.92)
Research Growth Index4.76 (4.65)
Search Engine Demand Index42.09 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.57)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other106 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]